Mohammad El Garhy | Medicine and Health Sciences | Best Innovation Award

Published on by Forensic Scientist Awards

Best Innovation Award

Mohammad El Garhy
Researcher Mohammad El Garhy
Affiliation Department of Internal Medicine I, Cardiology, University Hospital Jena
Country Germany
Scopus ID 57192109926
Documents 19
Citations 219
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-8578-0135

Mohammad El Garhy
Department of Internal Medicine I, Cardiology, University Hospital Jena, Germany

The Best Innovation Award recognizes scholarly contributions demonstrating scientific originality, translational relevance, and measurable impact within their respective disciplines. Mohammad El Garhy is a cardiology researcher whose academic work emphasizes structural heart disease, transcatheter cardiovascular interventions, multimodality imaging, and minimally invasive diagnostic technologies. His publications reflect continued participation in collaborative clinical research concerning transcatheter valve therapies, cardiovascular imaging, and interventional cardiology, contributing to evidence-based improvements in patient management.[1]

Abstract

Mohammad El Garhy has developed a publication record focused on interventional cardiology, cardiovascular imaging, and catheter-based structural heart interventions. His research addresses clinically important topics including transcatheter aortic valve implantation, MitraClip therapy, computed tomography-based valve assessment, and the expanding role of endoscopic ultrasound in cardiovascular diagnosis. These investigations contribute to improved procedural planning and patient outcomes while supporting innovation in minimally invasive cardiovascular medicine.[2]

Keywords

  • Interventional Cardiology
  • Transcatheter Valve Therapy
  • Cardiovascular Imaging
  • Structural Heart Disease
  • Medical Innovation

Introduction

Advances in structural heart interventions increasingly depend upon precise imaging, multidisciplinary clinical decision-making, and minimally invasive therapeutic strategies. Mohammad El Garhy’s scholarly work aligns with these developments by examining diagnostic technologies and transcatheter procedures that support evidence-based cardiovascular care. His publications have appeared in peer-reviewed journals dedicated to clinical cardiology and cardiovascular interventions.[3]

Research Profile

According to the supplied academic metrics, Mohammad El Garhy has authored 19 indexed publications with 219 citations and an h-index of 5. His primary research interests include transcatheter aortic valve implantation, mitral valve repair, computed tomography assessment of valvular disease, endoscopic ultrasound applications, and cardiovascular intervention planning.[1]

Research Contributions

  • Evaluation of transcatheter mitral valve repair outcomes.
  • Clinical assessment of porcelain aorta during TAVI procedures.
  • Studies comparing CT-based aortic valve calcium quantification methods.
  • Investigation of endoscopic ultrasound for cardiovascular diagnosis and intervention.
  • Clinical analyses supporting minimally invasive structural heart therapies.

Publications

  • The Role of Endoscopic Ultrasound in Cardiology (2026).
  • Impact of Porcelain Aorta on Outcomes in TAVI (2025).
  • Transcatheter Mitral Valve Repair via MitraClip (2023).
  • Contemporary Results of Transcatheter Mitral Valve Procedures (2022).
  • Aortic Valve Calcium Volume Assessment in TAVR Patients (2022).

Research Impact

The available publication record demonstrates continuing engagement in clinically relevant cardiovascular research. Studies addressing procedural optimization, diagnostic imaging, and structural heart interventions provide evidence that may support future improvements in patient care, multidisciplinary practice, and minimally invasive cardiovascular medicine.[4]

Award Suitability

Based on the documented publication record, research metrics, and emphasis on innovative cardiovascular diagnostics and interventions, Mohammad El Garhy’s scholarly activities demonstrate characteristics commonly considered during evaluations for innovation-oriented academic recognition. Award decisions remain dependent upon the official selection criteria established by the organizing committee.[5]

Conclusion

Mohammad El Garhy has contributed to contemporary cardiovascular medicine through investigations involving structural heart disease, catheter-based interventions, and advanced imaging. His research portfolio reflects ongoing participation in clinically significant studies that support evidence generation and innovation within interventional cardiology.

References

  1. Elsevier. Scopus Author Details: Mohammad El Garhy, Author ID 57192109926.
    https://www.scopus.com/authid/detail.uri?authorId=57192109926
  2. El Garhy M. The Role of Endoscopic Ultrasound in Cardiology. Journal of Clinical Medicine (2026). DOI:
    https://doi.org/10.3390/jcm15135006
  3. Open Heart. Impact of Porcelain Aorta on Outcomes in TAVI.
    https://doi.org/10.1136/openhrt-2024-003069
  4. Interventional Cardiology. Transcatheter Mitral Valve Repair via MitraClip.
    https://doi.org/10.15420/icr.2021.28
  5. The Egyptian Heart Journal. Contemporary Results of Transcatheter Mitral Valve Procedures.
    https://doi.org/10.1186/s43044-022-00257-x

Raffaelina Mercogliano | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Raffaelina Mercogliano
Affiliation Università Federico II di Napoli
Country Italy
Scopus ID 24830941800
Documents 52
Citations 1,376 citations by 1,259 documents
h-index 22
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0001-9167-4091

Raffaelina Mercogliano
Università Federico II di Napoli (Italy)

The Innovative Research Award profile recognizes the scholarly achievements and scientific contributions of Raffaelina Mercogliano, a researcher associated with Università Federico II di Napoli, Italy. Her academic portfolio reflects sustained contributions to medicine and health sciences, with a publication record demonstrating interdisciplinary engagement, research visibility, and measurable scientific impact. The recognition is presented within the framework of the International Forensic Scientist Awards and highlights excellence in research productivity, citation influence, and academic leadership.[1][2]

Abstract

This academic recognition profile summarizes the research accomplishments, publication activity, and scholarly influence of Raffaelina Mercogliano. The profile examines research productivity, citation performance, and disciplinary contributions within medicine and health sciences. Available bibliometric indicators suggest a sustained record of scientific engagement and international visibility, supporting consideration for recognition through the Innovative Research Award.[1][3]

Keywords

Innovative Research Award, Raffaelina Mercogliano, Medicine and Health Sciences, Scientific Recognition, Research Excellence, Citation Impact, Academic Achievement, Scholarly Publications, Health Research, International Forensic Scientist Awards.

Introduction

Academic awards play an important role in recognizing the contributions of researchers whose work advances scientific knowledge and professional practice. Evaluation criteria frequently include publication output, citation influence, research quality, and engagement with emerging scientific challenges. Within this context, the profile of Raffaelina Mercogliano reflects a research trajectory characterized by scholarly productivity and measurable impact within medicine and health sciences.[2][4]

Research Profile

Raffaelina Mercogliano is affiliated with Università Federico II di Napoli, one of Italy’s established research institutions. Her scholarly record includes 52 indexed documents and an h-index of 22, reflecting both productivity and sustained citation activity. The available citation metrics indicate broad engagement with her research findings across multiple publications and scientific communities.[1][2]

Research Contributions

The research contributions associated with this profile demonstrate engagement with topics relevant to medicine, health sciences, food safety, public health, and related interdisciplinary domains. Such work contributes to evidence-based practices, scientific understanding, and methodological advancement. The cumulative impact of these contributions is reflected through extensive scholarly citations and continued relevance within the academic literature.[3][5]

Publications

The publication portfolio comprises peer-reviewed scholarly articles indexed within internationally recognized academic databases. These publications contribute to the dissemination of scientific findings and support knowledge exchange among researchers, practitioners, and policy stakeholders. Consistent publication activity demonstrates a commitment to rigorous scientific investigation and scholarly communication.[1]

Research Impact

Research impact can be assessed through citation indicators, publication visibility, and scholarly influence. With 1,376 citations generated across 1,259 citing documents and an h-index of 22, the available metrics indicate meaningful engagement by the scientific community. Such indicators suggest that the research outputs have contributed to ongoing academic discussions and informed subsequent investigations within relevant fields.[1][4]

Award Suitability

Based on documented publication activity, citation performance, institutional affiliation, and demonstrated contributions to medicine and health sciences, Raffaelina Mercogliano presents a profile consistent with the objectives of the Innovative Research Award. The combination of scholarly productivity and measurable research influence supports recognition within international academic award frameworks designed to celebrate excellence and innovation in research.[2]

Conclusion

The scholarly record of Raffaelina Mercogliano reflects sustained academic engagement, recognized research output, and measurable citation influence. Through contributions to medicine and health sciences, the researcher has established a profile characterized by scientific relevance and professional accomplishment. These attributes provide a strong foundation for recognition through the Innovative Research Award and related international research excellence programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Raffaelina Mercogliano, Author ID 24830941800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24830941800
  2. ORCID. (n.d.). ORCID record for Raffaelina Mercogliano.
    https://orcid.org/0000-0001-9167-4091
  3. Mercogliano, R., et al. (2003). Scientific research in food safety and public health. DOI:
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. DOI:
    https://doi.org/10.1073/pnas.0507655102
  5. World Health Organization. (n.d.). Health research and evidence-informed policy resources.

Odayme Quesada | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Odayme Quesada | Medicine and Health Sciences | Research Excellence Award

University of Cincinnati, The Christ Hospital | United States

Assoc. Prof. Dr. Odayme Quesada is a clinician-scientist specializing in women’s cardiovascular health, with a strong focus on coronary microvascular and vasomotor dysfunction (CMVD), ANOCA, and MINOCA. Her research integrates innovative diagnostic strategies and targeted therapeutic approaches to improve cardiovascular outcomes in women. She has authored 78 Scopus-indexed publications, achieving 1,615 citations and an h-index of 22. Her scholarly contributions include high-impact journal articles, book chapters, and leadership in multicenter clinical trials. She has advanced specialized research programs and contributed significantly to understanding sex-specific cardiovascular risk factors and disease mechanisms.

                            Citation Metrics (Scopus)

2400

2000

1600

1200

800

400

0

 

Citations
1615
Documents
78
h-index
22

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Published on by Forensic Scientist Awards

Assist. Prof. Dr. Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Ordu University | Turkey

Dr. Fulya Erendor Cihan is an emerging researcher in gene and cell therapy, with a strong focus on precision gene editing, viral vector systems, and therapeutic strategies for metabolic and neurodegenerative diseases. Her work integrates advanced molecular biology techniques with translational research, particularly in diabetes, COVID-19 vaccine development, and neuroprotection. She has contributed to multiple nationally funded research projects and international collaborations, emphasizing lentiviral and adenoviral vector-based therapies. Her research outputs include high-impact journal publications, conference proceedings, and book chapters, reflecting her growing influence in biomedical innovation and experimental therapeutics.

                        Citation Metrics (Google Scholar)

300

250

200

150

100

50

0

 

Citations
150
Documents
25
h-index
5

Citations

Documents

h-index

View Google Scholar Profile  View ORCID Profile

Featured Publications


Gene and cell therapy of human genetic diseases: Recent advances and future directions

– Journal of Cellular and Molecular Medicine, 2024 | Cited by: 33

Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Prof. Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Zhongshan Hospital, Fudan University | China

Prof. Xuefei Wang is a leading researcher in gastric cancer biology and translational oncology, with over 100 peer-reviewed publications and significant citation impact. His work focuses on molecular mechanisms of tumor metastasis, DNA damage repair, and chemoradiotherapy resistance. He has contributed to high-impact journals such as Cell Death & Differentiation and Advanced Science. His research integrates CRISPR-based functional genomics, post-translational modifications, and targeted therapeutic development. He is actively involved in multi-institutional collaborations and serves as a reviewer for international SCI journals. His innovations include peptide-based therapeutic strategies targeting cancer resistance pathways.

View ORCID Profile  View ResearchGate Profile

Featured Publications

Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Dr. Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

University Hospitals Sussex | United Kingdom

Dr. Yasaman Salari is an emerging clinical researcher with a strong focus on ophthalmology, surgical outcomes, and translational medical research. Her scholarly contributions include first-author publications in peer-reviewed journals, notably addressing advanced glaucoma management and breast cancer surgical outcomes. She has presented research at international conferences and contributed to multidisciplinary studies spanning ophthalmology, neurology, and women’s health. Her ongoing research integrates innovative imaging technologies, simulation-based surgical training, and diagnostic advancements. Dr. Yasaman Salari demonstrates expertise in both quantitative and qualitative methodologies, contributing to evidence-based clinical practice and advancing patient-centered innovations in ophthalmic and surgical research.

                            Citation Metrics (Scopus)

6

5

4

3

2

1

0

 

Citations
0
Documents
2
h-index
0

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Dr. Marta Cudzik | Medicine and Health Sciences | Research Excellence Award

Institute of Psychiatry and Neurology | Poland

Dr. Marta Cudzik is a psychiatry-focused physician–researcher whose scholarly work lies at the intersection of neuroscience, emotional processing, and obesity-related mental health disorders. Her research examines how affective regulation, emotional intelligence, and trauma-related psychological mechanisms influence vulnerability to depression and other psychiatric conditions. She has authored peer-reviewed studies addressing emotional dysregulation, dissociative defense mechanisms in childhood trauma, and alexithymia among individuals with obesity, contributing clinically relevant insights to contemporary psychiatric research. A central theme of her work is the integration of psychological, neurobiological, and metabolic perspectives to better understand complex mind–body interactions. Dr. Marta Cudzik is developing an emerging interdisciplinary research direction referred to as psycho-obesitology, which seeks to bridge psychiatry and metabolic medicine through evidence-based frameworks. Her research aims to support more holistic diagnostic and therapeutic strategies in mental health, with implications for prevention, personalized treatment, and translational psychiatric care.

Profile: ORCID

Featured Publications

Cudzik, M., Lis, M., Wichniak, A., & Bieńkowski, P. (2026). Alexithymia among patients with obesity: A systematic review. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2025.12.030

Cudzik, M., Soroka, E., & Olajossy, M. (2019). The impact of emotional intelligence level on depression vulnerability. Current Problems of Psychiatry, 20(3). https://doi.org/10.2478/cpp-2019-0011

Cudzik, M., Soroka, E., & Olajossy, M. (2019). Dissociative identity disorder as a wide range of defense mechanisms in children with a history of early childhood trauma. Current Problems of Psychiatry, 20(2). https://doi.org/10.2478/cpp-2019-0006

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Assist. Prof. Dr. Xiaowen Mao | Medicine and Health Sciences | Best Researcher Award

University of Macau | Macau

Dr. Xiaowen Mao, M.D., Ph.D., is an Assistant Professor at the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, where she leads translational research on cancer biology, immunotherapy, and tumor microenvironment modulation. She earned her Ph.D. in Biomedical Sciences from the University of Hong Kong and her B.Sc. in Clinical Medicine from Shanghai Jiao Tong University, China. Her research focuses on extracellular vesicles, immune homeostasis, metabolic reprogramming in tumors, and hepatocellular carcinoma metastasis, integrating molecular, cellular, and translational approaches. Dr. Xiaowen Mao has led several high-impact projects as principal investigator, funded by the Health and Medical Research Fund, National Natural Science Foundation Young Scientist Fund, and FDCT Innovation and Technology Promotion. Her significant contributions include the development of broadly potent neutralizing antibodies targeting Nidogen 1 to inhibit tumor growth, elucidation of extracellular vesicle-mediated metabolic reprogramming in tumors, and advances in dendritic cell vaccine strategies. She holds a U.S. patent on Nidogen 1 as a diagnostic and therapeutic target for hepatocellular carcinoma, serves as Guest Editor for Frontiers in Endocrinology, and is an ad-hoc reviewer for multiple high-impact journals. According to Scopus, she has 31 publications, 1,114 citations by 1,010 documents, and an h-index of 20. Dr. Xiaowen Mao’s work bridges fundamental research and clinical translation, delivering innovative therapies and advancing precision medicine in oncology, while demonstrating a profound impact on cancer biology, immunotherapy, and translational research.

Profile: Scopus

Featured Publications

  • Xue, T. M., Yeung, C. L. S., Mao, X. W., Tey, S. K., Lo, K. W., Tang, H. N., Yun, J. P., & Yam, J. W. P. (2025). Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models. Journal of Translational Internal Medicine. https://doi.org/10.1515/jtim-2025-0008

  • Xia, L., Li, C. G., Zhao, J., Sun, Q. C., & Mao, X. W.* (2025). Rebalancing immune homeostasis in combating disease: The impact of medicine food homology plants and gut microbiome. Phytomedicine, 136, 156150. https://doi.org/10.1016/j.phymed.2025.156150

  • Chen, Z., Yam, J. W. P., & Mao, X. W.* (2024). The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments. Proteomics, e2300021. https://doi.org/10.1002/pmic.202300021

  • Lee, K. W., Yam, J. W. P., & Mao, X. W.* (2023). Dendritic cell vaccines: A shift from conventional approach to new generations. Cells, 12(2147). https://doi.org/10.3390/cells12172147

  • Li, S., Delvecchio, M., Ramkumar, K., Mao, X. W., Sun, X. D., & Guo, S. Z. (2023). Editorial: Clinical and genetic determinants of diabetes and complications. Frontiers in Endocrinology.

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479